market medtech - Robuta Search

https://www.medtechdive.com/news/acurable-launch-sleep-apnea-diagnosis/651232/ Acurable prepares to challenge ResMed for sleep apnea diagnosis market | MedTech Dive The company’s device records the sounds of the patient’s respiratory and cardiac functions and monitors blood oxygen levels to assess suspected obstructive... sleep apnea diagnosis market medtech dive prepares challenge resmed https://www.medtechdive.com/news/edwards-TAVR-data-TCT-limited-impact-surgeons/697262/ Physicians forecast Edwards’ 5-year data will have limited impact on low-risk TAVR market | MedTech... Some doctors think TAVR may perform numerically worse but see little impact on the market unless there is a statistically significant result. 5 year data limited impact low risk market medtech physicians https://www.medtechdive.com/news/nuvasive-buys-simplify-medical-150m/595778/ NuVasive buys Simplify Medical in play for $2.6B cervical spine market | MedTech Dive The $150 million acquisition will add to the pandemic-related challenges for NuVasive in 2021, with investments to train surgeons and run clinical trials... market medtech dive 2 6b cervical spine buys simplify https://www.medtechdive.com/news/hologic-fda-approval-transplant-testing-abbott-roche/623628/ Hologic gets FDA approval to challenge Abbott, Roche in transplant testing market | MedTech Dive The company plans to work toward approvals of transplant assays for other pathogens including the BK virus and Epstein-Barr virus to provide quantitative... gets fda approval market medtech dive hologic challenge abbott https://www.medtechdive.com/news/dexcom-cgm-adoption-booms-as-it-looks-to-aggressively-pursue-type-2-marke/559966/ Dexcom CGM adoption booms as it looks to 'aggressively' pursue Type 2 market | MedTech Dive Coming off another beat-and-raise quarter, the company remains focused on adding users via the pharmacy benefit channel, Medicare population and international... market medtech dive dexcom cgm type 2 adoption booms https://www.medtechdive.com/news/polares-raises-40m-to-target-competitive-mitral-regurgitation-market/580604/ Polares raises $40M to target competitive mitral regurgitation market | MedTech Dive The medtech plans to finish pilot clinical studies of a transcatheter mitral valve hemi-replacement device, seeking to treat a slice of a population that's... market medtech dive raises 40m mitral regurgitation polares target https://www.business-live.co.uk/technology/medtech-firm-corryn-biotechnologies-looking-33722666 Medtech firm Corryn Biotechnologies looking to the US market on equity funding boost | Business Live Apr 6, 2026 - The round was led by the Development Bank of Wales medtech firm us market equity funding boost business biotechnologies https://www.medtechdive.com/news/irhythm-IRTC-BSX-cardiac-monitor-zio/644420/ iRhythm, fighting Boston Scientific for market share, shows cardiac monitor beats rivals | MedTech... An analysis of Medicare claims data found iRhythm Technologies’ Zio XT outperforms other ambulatory cardiac monitors. boston scientific market share cardiac monitor irhythm fighting